DeepIntent LogoDoceree Logo

Healthcare Media & Clinician Networks

DeepIntent vs Doceree

Structured technology and market comparison · 2026

Direct Feature Comparison

DeepIntent · vs · Doceree
Direct Feature Comparison: DeepIntent vs Doceree
Attribute
DeepIntent LogoDeepIntent
Doceree LogoDoceree
Market Cluster / SectorHealthcare Media & Clinician NetworksHealthcare Media & Clinician Networks
Business Model / RoleAdTech Vendor · Data Provider / BrokerAdTech Vendor · Publisher & Media Owner
Platform FocusHealthcare-focused DSP and marketing cloud for pharmaceutical advertising.Healthcare adtech platform for pharma, publishers and HCP targeting.
Company Size201–500 employees201–500 employees
HeadquartersUnited StatesUnited States
Year Founded20162020
Dossier & Alternatives

Analyze all overlapping signals and tech stacks for DeepIntent and Doceree

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare in PlatformInstant access · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between DeepIntent and Doceree?

DeepIntent and Doceree are vertical healthcare adtech firms serving pharmaceutical advertisers and agencies, overlapping in HCP targeting and regulated media activation. DeepIntent positions as a programmatic DSP and marketing cloud emphasizing compliant data, audience creation and sector-specific attribution for enterprise buyers. Doceree leans into supply aggregation, publisher monetization and clinical workflow access, differentiating by stronger publisher and HCP workflow integrations.

How do the features of DeepIntent and Doceree compare?

Both platforms provide HCP audience targeting, campaign activation and healthcare measurement, but their product emphases differ. DeepIntent delivers a programmatic DSP and marketing-cloud stack with integrated audience building and sector-specific attribution for enterprise buying. Doceree emphasizes supply-side tooling, publisher monetization, clinical workflow integrations and transaction-enabled media activation—capabilities that extend monetization and direct HCP reach beyond a pure DSP.

What are the top alternatives to DeepIntent and Doceree?

When evaluating DeepIntent and Doceree, enterprise buyers also consider other platforms in Demand-Side Platform (DSP), Digital Out-of-Home (DOOH), and Native & Contextual Ads. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of DeepIntent and Doceree compare?

DeepIntent is headquartered in United States (founded in 2016) with 201–500 employees. Doceree is based in United States (founded in 2020) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: DeepIntent vs Doceree

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

DeepIntent Logo

DeepIntent

Recent Signals

  • ·VideoAmpProduct & Platform Launch

    VideoAmp Powers GumGum’s Sports Media Solution and DeepIntent’s Cora Launch

    The press release published on September 16, 2026 announces DeepIntent's launch of Cora, with VideoAmp powering linear TV planning and forecasting capabilities. The headline also states that VideoAmp powers GumGum's sports media solution. No financial terms or additional transaction details were included in the available release text.

    • Press release published on September 16, 2026.
    • DeepIntent announces the launch of Cora.
    • VideoAmp powers linear TV planning and forecasting capabilities for Cora.
  • ·AdExchangerProgrammatic

    OptimizeRx Partners with The Trade Desk for Programmatic

    OptimizeRx, a healthcare marketing technology company providing software subscriptions for drug-prescribing and record-keeping systems, is expanding into programmatic advertising. After an earlier partnership with healthcare-focused DSP DeepIntent, the company has now integrated with The Trade Desk. This move allows advertisers to target healthcare providers (HCPs) within electronic health records (EHRs) at the point of care. Targeting uses National Provider Identifiers (NPIs), ensuring precise, bot-free, fully viewable ad placements. OptimizeRx aims to maintain strict ad creative vetting to avoid misleading doctors. The partnership also opens opportunities for non-prescription brands, such as OTC products, to reach specific doctors based on geography and season. Over 99% of OptimizeRx's current ad business is tied to prescription drugs, but programmatic offers new revenue streams.

    • OptimizeRx has entered a new programmatic partnership with The Trade Desk.
    • The company previously partnered with healthcare DSP DeepIntent earlier this year.
    • OptimizeRx's ad inventory is within HCP electronic health records (EHRs) at the point of care.
  • ·DeepIntentProduct & Platform Launch

    DeepIntent Launches Cora, the First Fully Agentic Marketing Platform for Healthcare

    DeepIntent announced the launch of Cora, described as the first fully agentic marketing platform for healthcare, marking a significant product introduction.

Doceree Logo

Doceree

Recent Signals

  • ·DocereeProduct & Platform Launch

    Real Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals?

    Doceree's article argues that real-time HCP targeting should be measured by signal-to-exposure time, not just data freshness. It outlines four latency stages—signal detection, verified HCP identity, signal-to-activation, and activation-to-exposure—and recommends specific metrics for pharma teams. Doceree's Clinical Intent Signals combine EHR activity, prescribing behavior, and point-of-care context with verified provider identity for NPI-level targeting. Its Intent Powered HCP Suite activates these signals across point of care, programmatic, social, and CTV.

    • Doceree defines real-time HCP targeting as the time between a clinical event and the first relevant HCP exposure, not merely signal processing time.
    • The clinical signal path includes clinical activity → signal detection → HCP identification → audience activation → ad delivery, with potential latency at each stage.
    • Doceree's Clinical Intent Signals use EHR activity, prescribing behavior, point-of-care context, and other decision-moment signals, combined with verified provider identity for NPI-level targeting.
  • ·DocereeProduct & Platform Launch

    Highlights of the Fierce Pharma Week 2026

    On September 14, 2026, Doceree launched its Intent-Powered HCP Suite with a rooftop event and a 300-drone show over Philadelphia, followed by a three-day presence at Fierce Pharma Week 2026. The launch featured the new Daily Command decision layer and extended real-time clinical intent orchestration to CTV, social, and programmatic, alongside existing point-of-care and DOOH channels. During the week, Harshit Jain held a fireside chat with Maria Menounos on clinical intent, and Doceree hosted sessions on agentic AI and reaching all three moments of the prescription journey.

    • On September 14, 2026, Doceree hosted a Rooftop Social at Assembly Rooftop Lounge at The Logan Hotel in Philadelphia and launched its Intent-Powered HCP Suite with a 300-drone show over the city.
    • The drone show spelled 'Clinical Intent Signals' and 'Understand every intent. Improve every outcome.' above Philadelphia.
    • The Intent-Powered HCP Suite extends real-time clinical intent orchestration to CTV, Social, and Programmatic, complementing existing Care Sequence, DOOH, and Point of Care channels.

Start with a company or market. Track what changes.

Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.